A Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC
A Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC
Not yet recruiting · NCT07540832 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC | Advanced Hepatocellular Carcinoma (HCC) | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-15 | NCT07540832 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Haichang Biotech Co., Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |